We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi Reaches More Settlements on Release of Generic Eloxatin
Sanofi Reaches More Settlements on Release of Generic Eloxatin
April 13, 2010
Sanofi-Aventis has reached settlement agreements with Hospira, Par Pharmaceutical and Actavis that would allow the generic companies to join three others in introducing generic versions of Sanofi’s Eloxatin colorectal cancer drug in 2012.